학술논문

PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors
Document Type
Article
Source
In: OncoImmunology. (OncoImmunology, 2022, 11(1))
Subject
Language
English
ISSN
2162402X
21624011